A recent study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands, shows promise with a breath test measuring five chemicals in the detection of possible gastric and oesophageal cancers.
Results from a study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands showed that rapid deterioration of type 2 diabetes after diagnosis may be an early sign of pancreatic cancer.
Findings of two studies presented recently at the European Cancer Congress 2017 (ECCO 2017) demonstrates the effect of the PD-1 inhibitor, pembrolizumab, against a rare form of melanoma and bladder cancer.
Women above 50 years of age with ductal carcinoma in situ (DCIS) have a lower risk of all-cause mortality at 10 years compared with the general population, new data presented at the European Cancer Congress 2017 (ECCO 2017)have shown.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Pharmacist - Malaysia digital copy today!
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
In patients with atrial fibrillation (AF) naïve to oral anticoagulants (OACs), standard-dose nonvitamin K antagonist OACs (NOACs) provides better survival benefits than warfarin, a recent meta-analysis has shown.
Use of diclofenac, a traditional nonsteroidal anti-inflammatory drug (NSAID) with cyclo-oxygenase-2 (COX-2) selectivity similar to COX-2 inhibitors, is associated with higher cardiovascular health risk compared with nonuse, paracetamol use and use of other traditional NSAIDs, a recent study has shown.